Marcus M.
- Country
- Germany
- Department
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine
Research Overview
- A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Subjects with Cystic Fibrosis Aged 18Years or Older (CHOICES)
- Evaluation of Efficacy, Safety, and Pharmacokinetics of Inhaled ETD001 in Cystic Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Study
- A randomised, double-blind, placebo-controlled, parallel group trial evaluating safety, tolerability, pharmacodynamics and pharmacokinetics of BI 1291583 one tablet once daily over 12 weeks versus placebo in adult patients with cystic fibrosis bronchiectasis (ClairaflyTM)
Data & Insights
Has run more than one trial at 54 of 194 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular expertise in bronchiectasis and cystic fibrosis. Their research encompasses both adult and pediatric populations, demonstrating comprehensive involvement in respiratory medicine.
- Non-CF Bronchiectasis
- Cystic Fibrosis Bronchiectasis
- Pediatric Respiratory Disorders
Their work includes evaluation of novel therapeutic approaches for bronchial conditions across different age groups.
Therapeutic Innovation
The investigator focuses on evaluating emerging treatments for respiratory conditions, particularly CFTR modulators and novel therapeutic compounds. Their research includes assessment of both established and investigational medications.
- Novel Respiratory Therapeutics
- Long-term Safety Studies
- Treatment Efficacy Assessment
Their expertise extends to studying medication effects in various patient populations, from infants to adults.
Clinical Trial Expertise
The investigator conducts research in rare genetic respiratory disorders and their treatment options. Their work encompasses both short-term and long-term clinical evaluations of therapeutic interventions.
- Safety and Tolerability Studies
- Age-Specific Treatment Protocols
- Rare Mutation Research
Their research includes specialized studies for patients with specific genetic variants and treatment responses.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.